Market Highlights: Ibuprofen is a non steroidal anti-inflammatory drug (NSAIDs) used as a painkiller as well as for treating fever and inflammation. This medication can be available to take without doctor's prescriptions. It also pain and inflammation caused by conditions that effect joints, bones, and muscles. In addition to this, Ibuprofen also reduces migraine, toothache and others. It was initially developed in 1960 while researching for a safer alternative for aspirin. The market study is being classified by Type (USP and EP) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Ibuprofen Sales are Xinhua Pharmaceutical (China), IOLCP (India), Granules Biocause (China), Strides Pharma Science Limited. (India), BASF (Germany), SI Group, Inc. (United States), Xinhua-Perrigo Pharmaceutical (China), Hisoar (China), Unipex (France) and Rochem (United States).
On 9th August, 2018, SI Group Inc. has announced that it will be increasing its capacity for ibuprofen manufacture by 25%, to be completed by 2020.
Key Questions Answered in the Report What will the Ibuprofen Sales Market size and the growth rate be in Future? What are the key factors driving the Ibuprofen Sales Market? What are the key market trends and macro-economic impacting the growth of the Ibuprofen Sales Market? What are the challenges to market growth? Who are the key vendors in the Ibuprofen Sales Market? What are the market opportunities and threats faced by the vendors in the Ibuprofen Sales Market? Trending factors influencing the market shares of the Vendors. What are the key outcomes of the five forces analysis of the Ibuprofen Sales Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Ibuprofen Sales market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Ibuprofen Sales market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Ibuprofen Manufacturers, Ibuprofen Distributors Traders, Government and Private Health Care Organisations, Hospitals, Medical Institutes and Others. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.